Test whether F-choline PET scans help in new conditions
Part of Brain & nervous system, Cancer clinical trials.
This study checks how useful an F-choline PET scan is for finding information in people with known or suspected conditions. It may help doctors decide what to look for or how to guide care in “new and emerging” situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a person with a known or suspected condition where an F-choline PET scan could help doctors
- You are 18 years old or older
- You are not pregnant
- You are not breastfeeding, or you are willing to stop breastfeeding for 48 hours
- You do not have a known allergy to F-choline or any scan ingredients
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a PET/CT scan using a tracer called 18F-fluorocholine can better identify tumors. It may help doctors more accurately find and characterize tumors to guide treatment.
This Phase 3 study looks at how a PSMA PET scan can predict how prostate cancer will progress and how well treatment is working. If your doctor at CHUM orders this scan, you may be able to join to help refine better predictions for future patients.
This study uses a special imaging scan (PET/MR) with a tracer called fluorocholine to see if it can help evaluate breast cancer before treatment or before surgery. It is for women who are newly diagnosed with breast cancer and will either have chemotherapy before surgery or go straight to surgery.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study compares different scan types (MRI, CT, and two PET scans) in people with hepatocellular carcinoma (a primary liver cancer). It may help doctors figure out which scan gives the most useful information for diagnosis and treatment planning.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
Hear when a new Lesion With Known or Suspected F-choline Uptake trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.